REG - IXICO plc - PDMR share sale

IXICOAnnouncement

09/12/2019 09:30

RNS Number : 1861W
IXICO plc
09 December 2019
 


HEADLINE ALTERATION
 
The headline for the IXICO plc. announcement released on 09/12/2019 at 07:00 am under RNS No 1254W should read PDMR share sale.
 
The announcement text is unchanged and is reproduced in full below.
 
 
09 December 2019
 
IXICO plc
("IXICO" or the "Company")
 
PDMR share sale
IXICO plc (AIM: IXI), the data analytics company delivering insights in neuroscience, announces that it received notification on 6 December 2019 that on 5 December 2019 John Hall, SVP Corporate Development and a PDMR, sold 100,000 ordinary shares at an aggregated price of 68.00p.
 



1
 


Details of the person discharging managerial responsibilities / person closely associated
 




a)
 


Name
 
 


John James Hall
 




2
 


Reason for the notification
 




a)
 


Position/status
 
 


PDMR (SVP Corporate Development)




b)
 


Initial notification /Amendment
 
 


Initial notification




3
 


Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
 




a)
 


Name
 
 


IXICO plc




b)
 


LEI
 
 


2138005M1F59O6HWSA97




4
 


Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
 
 




a)
 


Description of the financial instrument, type of instrument


Ordinary Shares in IXICO plc














Identification code


GB00BCLY7L40




 








b)
 


Nature of the transaction
 
 


Sale




c)
 


Price(s) and volume(s)


 


 


 


 








 


Price(s)


Volume(s)


 








 


68p


100,000


 








 


 


 


 








 


 


 


 




d)
 


Aggregated information


















- Aggregated volume


100,000 shares














- Price


68p














e)
 


Date of the transaction
 
 


5/12/19




f)
 


Place of the transaction
 
 


London Stock Exchange, AIM Market (IXI), UK



 



IXICO plc


+44 (0) 20 3763 7498




Giulio Cerroni, Chief Executive Officer








Grant Nash, Chief Financial Officer
 








Cenkos Securities PLC (Nominated adviser and sole broker)


+44 (0) 20 7397 8900




Giles Balleny / Max Gould (Corporate Finance)








Michael F Johnson / Russell Kerr (Sales)


















Optimum Strategic Communications


 +44 (0) 203 950 9144




Mary Clark / Supriya Mathur / Manel Mateus








ixico@optimumcomms.com







 




This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
DSHLIFFAFSLAIIA